Surgical Navigation Systems Market by Application Technology - Global Forecast 2021

The global surgical navigation systems market is expected to reach USD 906.8 Million by 2021 from USD 662.5 Million in 2016, at a CAGR of 6.5% during the forecast period (2016–2021). Growth of this market is primarily driven by factors such as the rising adoption of minimally invasive surgical procedures; growing number of regulatory approvals, and partnerships, agreements, and collaborations among market players; increasing incidence of orthopedic and neurological disorders; and high prevalence of ENT disorders. However, the high cost of surgical navigation systems and product recalls are likely to create a negative impact on the growth of this market.

The market is categorized on the basis of technology, application, patient care setting, and region. Based on technology, the market is categorized into optical navigation systems, electromagnetic (EM) navigation systems and hybrid navigation systems. The optical navigation systems segment is poised to grow at the highest CAGR during the forecast period owing to its advantages over EM systems such as reduced radiation exposure and accuracy provided during complex surgeries, which enable surgeons to navigate properly through a patient’s anatomy. In addition to this, rise in awareness regarding the advantages of optical systems are also influencing the growth of the market.

North America is estimated to account for the largest share of the global market in 2016, followed by Europe. The dominance of the North American market is due to the high prevalence of ENT disorders, growing adoption of minimally invasive surgeries, government funding for the development of surgical navigation systems, increasing adoption by ambulatory settings, and increasing regulatory approvals.

Prominent players in this market include Medtronic plc (Ireland), Stryker Corporation (U.S.), Brainlab AG (Germany), B. Braun Melsungen AG (Germany), Scopis GmbH (Germany), Fiagon AG (Germany), Karl Storz GmbH & Co. KG (Germany), Amplitude Surgical (France), Zimmer Biomet Holdings, Inc. (U.S.), and Siemens Healthineers (Germany).


Comments